References
- Gonzalez‐Gay M., García P. Epidemiology of the vasculitides. Rheum Dis Clin North Am 2001; 27: 729–49
- Somer T., Finegold S. Vasculitides associated with infections, immunization and antimicrobial drugs. Clin Infect Dis 1995; 20: 1010–36
- Gerber O., Roque C., Coyle P. Vasculitis owing to infection. Neurol Clin 1997; 15: 903–25
- Hamidou M., Fradet G., Kadi A., Robin A., Moreau A., Magnaval J. Systemic vasculitis with lymphocytic temporal arteritis and Toxocara canis infection. Arch Int Med 2002; 162: 1521–4
- Narvaez J., Biosca M., Perez‐Vega C., Vilaseca‐Momplet J. Fulminant systemic vasculitis in a patient with untreated asymptomatic chronic hepatitis C infection. Scand J Rheumatol 2003; 32: 374–5
- Atias A. Parasitología médica. Editorial Mediterráneo, Santiago 1999
- Chester P., Clifton R., Wayne E. Medical parasitology. Salvat, Barcelona 1986
- Apt W., Aguilera X., Vega F., Miranda C., Zulantay I., Perez C., et al. Treatment of human chronic fasciolasis with triclabendazole: drug efficacy and serologic response. Am J Trop Med Hyg 1995; 52: 532–5
- Jennette C., Falk R. Small‐vessel vasculitis. N Engl J Med 1997; 337: 1512–23
- Klippel J., Crofford L., Stone J., Weyand C, editors. Primer on the rheumatic diseases. Arthritis Foundation, Atlanta, Georgia 2001
- Merkel P. A. Drug‐induced vasculitis. Rheum Dis Clin North Am 2001; 27: 849–62
- Naides S. Known infectious causes of vasculitis in man. Cleve Clin J Med 2002; 69 Suppl 2: SII15–19
- Oujamaa L., Sibon I., Vital A., Menegon P. Cerebral vasculitis secondary to Toxocara canis and Fasciola hepatica co‐infestation. Rev Neurol (Paris) 2003; 159: 447–50
- Lee N., McNeely W., Shepard J., Ebeling S., Ellender S., Peters C. 50‐year‐old man with eosinophilia and fluctuating hepatic lesions. N Engl J Med 2002; 346: 1232–39